Estadística e Investigación Operativa
Département
Centro de Investigación Biomédica en Red sobre Enfermedades Raras
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Raras (35)
2021
2020
-
Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
Theranostics, Vol. 10, Núm. 11, pp. 5120-5136
2019
-
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Oncologist, Vol. 24, Núm. 8, pp. e784-e792
-
Deep sequencing reveals microRNAs predictive of antiangiogenic drug response
JCI Insight, Vol. 1, Núm. 10
-
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma
Theranostics, Vol. 9, Núm. 17, pp. 4946-4958
2018
-
Gain-of-function mutations in DNMT3A in patients with paraganglioma
Genetics in Medicine, Vol. 20, Núm. 12, pp. 1644-1651
2017
-
Genetic variation in the NEIL2 DNA glycosylase gene is associated with oxidative DNA damage in BRCA2 mutation carriers
Oncotarget, Vol. 8, Núm. 70, pp. 114626-114636
-
Multilayer OMIC Data in medullary thyroid carcinoma identifies the STAT3 pathway as a potential therapeutic target in RETM918T Tumors
Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1334-1345
-
Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer
PLoS ONE, Vol. 12, Núm. 7
-
Targeted sequencing reveals low-frequency variants in EPHA genes as markers of paclitaxel-induced peripheral neuropathy
Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1227-1235
2016
-
Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers
Oncotarget, Vol. 7, Núm. 18, pp. 25815-25825
2015
-
DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers
Clinical Cancer Research, Vol. 21, Núm. 13, pp. 3020-3030
-
Functional and in silico assessment of MAX variants of unknown significance
Journal of Molecular Medicine, Vol. 93, Núm. 11, pp. 1247-1255
-
High frequency and founder effect of the CYP3A4∗20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme
Pharmacogenomics Journal, Vol. 15, Núm. 3, pp. 288-292
-
MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors
Modern Pathology, Vol. 28, Núm. 6, pp. 748-757
-
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
Journal of Medical Genetics, Vol. 52, Núm. 10, pp. 647-656
-
Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations
International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878
-
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene
Journal of the National Cancer Institute, Vol. 107, Núm. 5
2014
-
DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
International Journal of Cancer, Vol. 135, Núm. 3, pp. 598-610